Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by MrMugsyon Jun 05, 2022 9:02pm
252 Views
Post# 34732963

Chi-Chi is so scared ...

Chi-Chi is so scared ...He's playing right into my hands at ATE (from what I'm hearing).

He can't believe that my purchase price at GUD is around $6.50, my purchase price at ATE is about $1.35 and that I sold off PRN for profits and am buying back now.

------------------------------------

By the way - the last time I spoke to Samira about it a year and a half ago (if I didn't say) - she didn't see a near-term use for Profound's Tulsa Pro in Canada ... there are just too many barriers in Canada right now.
1.  not enough MRIs to go around
2.  reimbursement isn't available re. payment

But when I talked to Profound's CEO (around the same time) ... he thought that eventually the customer need will be high.  USA will lead. 

Patients will see the high level of safety in protecting the nerve bundle associated with impotence.  Same day prostate cancer surgery and heading home, using 55 degree ultrasound to burn the prostate cancer will surely become the go-to.  Looked really good at this years AUA meeting with a semi-live operation for meeting attendees.

Until Canada gets with the plan ... Samira does see other specific market opportunities where she would like to get access to the TULSA-PRO from Profound.  That opportunity is still out there and is a potential for GUD.

Time will tell if we gain other makets or stick to Canada alone.

COVID has been a bummer for these opperations in the USA as everything had slowed to a crawl.  Back at er now with growing partnerships in the USA !!!

So many opportunities out there for GUD !!!!
<< Previous
Bullboard Posts
Next >>